Condition
Primary Hyperlipidemia
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
P 2 (1)
P 3 (2)
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07623915Phase 3Not Yet RecruitingPrimary
A Clinical Study to Evaluate the Efficacy and Safety of Bempedoic Acid
NCT06822946Phase 2RecruitingPrimary
Zhibitai Capsules for the Treatment of Primary Hyperlipidemia
NCT06780410Phase 3RecruitingPrimary
A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid
Showing all 3 trials